Gentis

Gentis is a developer of minimally invasive, biomaterial-based products aimed at treating early-stage spinal degeneration. The company's patented product is DiscCell, an injectable, in-situ curing, radiopaque, non-hydrogel polymer material designed to enhance or replace the damaged nucleus pulposus of intervertebral discs.